Source:http://linkedlifedata.com/resource/pubmed/id/16537571
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-4-3
|
pubmed:abstractText |
The hereditary spastic paraplegias (HSPs) (SPG1-29) comprise a group of inherited neurological disorders characterized principally by spastic lower extremity weakness due to a length-dependent, retrograde axonopathy of corticospinal motor neurons. Mutations in the gene encoding the dynamin superfamily member atlastin-1, an oligomeric GTPase highly localized to the Golgi apparatus in the adult brain, are responsible for SPG3A, a common autosomal dominant HSP. A distinguishing feature of SPG3A is its frequent early onset, raising the possibility that developmental abnormalities may be involved in its pathogenesis. Here, we demonstrate that several missense SPG3A mutant atlastin-1 proteins have impaired GTPase activity and thus may act in a dominant-negative, loss-of-function manner by forming mixed oligomers with wild-type atlastin-1. Using confocal and electron microscopies, we have also found that atlastin-1 is highly enriched in vesicular structures within axonal growth cones and varicosities as well as at axonal branch points in cultured cerebral cortical neurons, prefiguring a functional role for atlastin-1 in axonal development. Indeed, knock-down of atlastin-1 expression in these neurons using small hairpin RNAs reduces the number of neuronal processes and impairs axon formation and elongation during development. Thus, the "long axonopathy" in early-onset SPG3A may result from abnormal development of axons because of loss of atlastin-1 function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0964-6906
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1343-53
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16537571-Animals,
pubmed-meshheading:16537571-Axons,
pubmed-meshheading:16537571-Brain,
pubmed-meshheading:16537571-Central Nervous System,
pubmed-meshheading:16537571-DNA-Binding Proteins,
pubmed-meshheading:16537571-GTP Phosphohydrolases,
pubmed-meshheading:16537571-GTP-Binding Proteins,
pubmed-meshheading:16537571-Growth Cones,
pubmed-meshheading:16537571-Immunohistochemistry,
pubmed-meshheading:16537571-Microscopy, Electron,
pubmed-meshheading:16537571-Neurons,
pubmed-meshheading:16537571-Rats,
pubmed-meshheading:16537571-Rats, Sprague-Dawley,
pubmed-meshheading:16537571-Spastic Paraplegia, Hereditary
|
pubmed:year |
2006
|
pubmed:articleTitle |
SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development.
|
pubmed:affiliation |
Cellular Neurology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 35, 35 Convent Drive, Bethesda, MD 20892, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|